Medication

FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. How much members of the Sackler family should be held accountable for the role their company, Purdue Pharma, played in the nation’s opioid crisis will be at the center of a hearing in federal bankruptcy court. State attorneys general who are pressing separate state claims against the Sacklers want their cases to continue even as Purdue’s bankruptcy case plays out. They will make that argument on Friday, Oct. 11, 2019 before a bankruptcy judge in White Plains, New York. (AP Photo/Frank Franklin II, File)
October 11, 2019 - 8:02 pm
WHITE PLAINS, N.Y. (AP) — A judge is pushing for a settlement of more than 2,600 lawsuits facing OxyContin maker Purdue Pharma with a decision Friday to pause litigation against the company and members of the wealthy Sackler family that owns the company. In a hearing Friday, U.S. Bankruptcy Judge...
Read More
FILE - In this July 30, 2013, file photo, people walk along a corridor at the headquarters of Johnson & Johnson in New Brunswick, N.J. A Philadelphia jury has ruled that Johnson & Johnson and Janssen Pharmaceuticals must pay $8 billion in punitive damages over an antipsychotic drug linked to the abnormal growth of female breast tissue in boys. A law firm for the plaintiff released a statement Tuesday, Oct. 8, 2019, saying the companies used an organized scheme to make billions of dollars while illegally marketing and promoting the drug called Risperdal. (AP Photo/Mel Evans, File)
October 08, 2019 - 8:27 pm
PHILADELPHIA (AP) — A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked to the abnormal growth of female breast tissue in boys. Johnson and Johnson...
Read More
Professor Gregg Semenza, accompanied by Johns Hopkins University President Ron Daniels, waves to the crowd during a news conference after he was awarded the 2019 Nobel Prize in Medicine at Johns Hopkins Medicine Hospital in Baltimore, Md., Monday, Oct. 7, 2019. The 2019 Nobel Prize in Medicine has been jointly awarded to William Kaelin Jr., Sir Peter Ratcliffe and Gregg Semenza for their pioneering research into how human cells respond to changing oxygen levels. (AP Photo/Jose Luis Magana)
Associated Press
October 07, 2019 - 8:35 pm
NEW YORK (AP) — Two Americans and a British scientist won a Nobel Prize on Monday for discovering details of how the body's cells sense and react to low oxygen levels, providing a foothold for developing new treatments for anemia, cancer and other diseases. Drs. William G. Kaelin Jr. of Harvard...
Read More
This undated photo provided by Johns Hopkins University shows Gregg L. Semenza at the university in Baltimore. Semenza, a Johns Hopkins University researcher, was awarded the Nobel Prize for Physiology or Medicine on Monday, Oct. 7, 2019. He will share the prize with Drs. William G. Kaelin Jr. and Peter J. Ratcliffe for their discoveries of how cells sense and adapt to oxygen availability, the Nobel Committee announced Monday. (Johns Hopkins University via AP)
October 07, 2019 - 8:48 am
STOCKHOLM (AP) — The Latest on the Nobel Prize in Medicine or Physiology (all times local): 2:40 p.m. Dr. Gregg Semenza, a top researcher at Johns Hopkins University in Baltimore, says he was awakened by a call from Stockholm shortly before 4 a.m. with the good news that he is one of three...
Read More
FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. How much members of the Sackler family should be held accountable for the role their company, Purdue Pharma, played in the nation’s opioid crisis will be at the center of a hearing in federal bankruptcy court. State attorneys general who are pressing separate state claims against the Sacklers want their cases to continue even as Purdue’s bankruptcy case plays out. They will make that argument on Friday, Oct. 11, 2019 before a bankruptcy judge in White Plains, New York. (AP Photo/Frank Franklin II, File)
October 04, 2019 - 5:26 pm
Attorneys general representing nearly half the states and lawyers for more than 500 local governments on Friday blasted the terms of Purdue Pharma's offer to settle thousands of lawsuits over the nation's opioid crisis in court filings that also said the company had funneled up to $13 billion to...
Read More
FILE - In this July 30, 2013, file photo, large banners hang in an atrium at the headquarters of Johnson & Johnson in New Brunswick, N.J. Johnson & Johnson has become the latest company to settle a lawsuit to get out of the first federal trial over the nation's opioids crisis, reaching a deal worth more than $20 million with two Ohio counties, the company announced Tuesday, Oct. 1, 2019. (AP Photo/Mel Evans, File)
Associated Press
October 01, 2019 - 9:28 pm
Johnson & Johnson on Tuesday announced it had reached an agreement worth more than $20 million with two Ohio counties, becoming the latest company to settle a lawsuit to get out of the first federal trial over the nation's opioids crisis. The deal with Cuyahoga and Summit counties comes a...
Read More
FILE - In this June 6, 2017 file photo, an example of the amount of fentanyl that can be deadly after a news conference about deaths from fentanyl exposure, at DEA Headquarters in Arlington Va. The Justice Department’s inspector general says the Drug Enforcement Administration was “slow to respond” as America grappled with a rising opioid epidemic. The watchdog released a report Tuesday examining the agency’s regulatory and enforcement efforts to control opioids. (AP Photo/Jacquelyn Martin, File)
October 01, 2019 - 2:35 pm
WASHINGTON (AP) — The Drug Enforcement Administration was "slow to respond" as America grappled with a rising opioid epidemic, the Justice Department's inspector general said in a report Tuesday that faulted the agency for cutting back use of a key enforcement tool and continuing to raise...
Read More
A box of Maximum Strength Zantac tablets is shown at a pharmacy, Monday, Sept. 30, 2019, in Miami Beach, Fla. CVS has halted sales of the popular heartburn treatment and the store generic version after warnings by U.S. health regulators. (AP Photo/Wilfredo Lee)
September 30, 2019 - 4:14 pm
CVS has halted sales of popular heartburn treatment Zantac and its generic store brand after warnings by U.S. health regulators. It's the latest precautionary move by retailers and manufacturers after the U.S. Food and Drug Administration recently warned consumers about a potentially dangerous...
Read More
In this photo taken Sept. 20, 2019, David Alport, owner of the Bridge City Collective marijuana dispensary in Portland, Ore., goes over sales numbers with the store's general manager Cameron Moore. The company has seen a 31% decrease in its sales of vaping products in the past two weeks. “It’s having an impact on how consumers are behaving,” said Alport. “People are concerned, and we’re concerned.” (AP Photo/Gillian Flaccus)
September 26, 2019 - 8:55 pm
PORTLAND, Ore. (AP) — Vaping products, one of the fastest-growing segments of the legal marijuana industry, have taken a hit from consumers as public health experts scramble to determine what's causing a mysterious and sometimes fatal lung disease among people who use e-cigarettes. The ailment has...
Read More
FILE - In this Oct. 2, 2016 file photo, Mac Miller performs at the 2016 The Meadows Music and Arts Festivals at Citi Field in Flushing, New York. Authorities say an Arizona man has become the second person arrested on drug charges in the investigation of the overdose death of the rapper. Havasu City, Ariz., police said Tuesday, Sept. 24, 2019, that Ryan Reavis has been charged with possession of marijuana and prescription drugs. (Photo by Scott Roth/Invision/AP, File)
September 25, 2019 - 3:41 pm
LOS ANGELES (AP) — An Arizona man has become the second person arrested on drug charges in the investigation of the overdose death of rapper Mac Miller, authorities said. Ryan Reavis, 36, was charged in Mohave County court with possession of marijuana, prescription drugs and drug paraphernalia;...
Read More

Pages